Vorapaxar in secondary prevention: where we stand.

Vorapaxar in secondary prevention: where we stand. Curr Med Res Opin. 2017 Jun 10;:1-6 Authors: Kei A, Elisaf M Abstract This editorial accompanies an original article being published by the Current Medical Research and Opinion (CMRO) journal, entitled "State transition model: vorapaxar added to standard antiplatelet therapy to prevent thrombosis post myocardial infarction or peripheral artery disease". In this editorial we consider some aspects of the use of vorapaxar in secondary prevention in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD). PMID: 28604119 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research